Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Evaluation of the Impact of Emotional Skills of Young Women (≤ 45 Years), With Non-metastatic Breast Cancer, and Their Partner on Adjustment to Cancer
Authors not listed
Centre Oscar Lambret · 2016
Abstract
The KALICOU 3 study will evaluate the effect of emotional skills of patients and their partners on their individual disease subjective experience during care pathways, from chemotherapy to surveillance.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-14 MST
Cite this
APA
Anonymous. (2016). Evaluation of the Impact of Emotional Skills of Young Women (≤ 45 Years), With Non-metastatic Breast Cancer, and Their Partner on Adjustment to Cancer. <em>Centre Oscar Lambret</em>. https://clinicaltrials.gov/study/NCT02861742
Vancouver
Anonymous. Evaluation of the Impact of Emotional Skills of Young Women (≤ 45 Years), With Non-metastatic Breast Cancer, and Their Partner on Adjustment to Cancer. Centre Oscar Lambret. 2016.
BibTeX
@misc{anon2016Evalua,
title = {Evaluation of the Impact of Emotional Skills of Young Women (≤ 45 Years), With Non-metastatic Breast Cancer, and Their Partner on Adjustment to Cancer},
author = {Anonymous},
journal = {Centre Oscar Lambret},
year = {2016},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nature 1996
Citation only
A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegans
University of Michigan 2022
Open access · US-GOV
An Observational Study of Women With Breast Cancer Examining the Effect of Endocrine Therapy on Aging
The University of Texas Health Science Center at San Antonio 2012
Open access · US-GOV
A Pilot Trial of Frailty Assessment in Older Adults (Age 70 >) Requiring Concurrent Chemotherapy Plus Radiation Therapy for Cancer (CTRC# 12-22)
CNAO National Center of Oncological Hadrontherapy 2023
Open access · US-GOV
Role of Baseline Sarcopenia in Determining Acute Toxicity for Head and Neck Cancer Patients Treated with Curative Hadrontherapy: a Prospective Monoinstitutional Study
Vtesse, LLC, a Mallinckrodt Pharmaceuticals Company 2020
Open access · US-GOV
An Open-label, Multicenter Safety and Tolerability Study of VTS-270 (2-hydroxypropyl-β-cyclodextrin) in Pediatric Subjects Aged < 4 Years With Neurologic Manifestations of Niemann-Pick Type C (NPC) Disease
Biomaterials 2014
Citation only